I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wilkerson, Paul J.
206
results:
Search for persons
X
Format
Online (206)
Mediatypes
E-Books (1)
Articles (Online) (80)
Bookchapter (Online) (6)
OpenAccess-fulltext (119)
Sorted by: Year
Sorted by: Relevance
?
1
Supplementary Figure S5 from Phase II Clinical Trial of Pem..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947896.v1. , 2024
Link:
https://doi.org/10.1158/..
?
2
Supplementary Figure S2 from Phase II Clinical Trial of Pem..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947905.v1. , 2024
Link:
https://doi.org/10.1158/..
?
3
Supplementary Table S3 from Phase II Clinical Trial of Pemb..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947887.v1. , 2024
Link:
https://doi.org/10.1158/..
?
4
Supplementary Table S2 from Phase II Clinical Trial of Pemb..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947890.v1. , 2024
Link:
https://doi.org/10.1158/..
?
5
Supplementary Figure S4 from Phase II Clinical Trial of Pem..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947899.v1. , 2024
Link:
https://doi.org/10.1158/..
?
6
Supplementary Figure S1 from Phase II Clinical Trial of Pem..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947908.v1. , 2024
Link:
https://doi.org/10.1158/..
?
7
Supplementary Table S1 from Phase II Clinical Trial of Pemb..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947893.v1. , 2024
Link:
https://doi.org/10.1158/..
?
8
Supplementary Figure S3 from Phase II Clinical Trial of Pem..:
Avia D. Wilkerson
;
Prerana Bangalore Parthasarathy
;
Nickolas Stabellini
...
doi:10.1158/1078-0432.24947902.v1. , 2024
Link:
https://doi.org/10.1158/..
?
9
Understanding the Experiences of Latinx LGBTQ Texans at the..:
Dorri, Armin A.
;
Loza, Oralia
;
Bond, Mark A.
...
Journal of Homosexuality. 71 (2023) 10 - p. 2424-2448 , 2023
Link:
https://doi.org/10.1080/..
?
10
Fluorescence and Absorbance Indices for Dissolved Organic M..:
Fischer, Sarah J.
;
Fegel, Timothy S.
;
Wilkerson, Paul J.
...
ACS ES&T Water. 3 (2023) 8 - p. 2199-2209 , 2023
Link:
https://doi.org/10.1021/..
?
11
Phase II Clinical Trial of Pembrolizumab and Chemotherapy R..:
Wilkerson, Avia D.
;
Parthasarathy, Prerana Bangalore
;
Stabellini, Nickolas
...
Clinical Cancer Research. 30 (2023) 1 - p. 82-93 , 2023
Link:
https://doi.org/10.1158/..
?
12
Targeted Proteomic Quantitation of NRF2 Signaling and Predi..:
Wamsley, Nathan T.
;
Wilkerson, Emily M.
;
Guan, Li
...
Molecular & Cellular Proteomics. 22 (2023) 11 - p. 100647 , 2023
Link:
https://doi.org/10.1016/..
?
13
Mechanics of hypervelocity simultaneously launched distribu..:
Rogers, Jacob A.
;
Mead, Paul T.
;
Lukasik, Gavin
...
International Journal of Impact Engineering. 180 (2023) - p. 104671 , 2023
Link:
https://doi.org/10.1016/..
?
14
Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Pe..:
John R. Prowle, MD
;
Antonio Artigas, MD
;
Sean M. Bagshaw, MD
...
http://journals.lww.com/10.1097/CCE.0000000000000870. , 2023
Link:
https://doi.org/10.1097/..
?
15
The Texas A&M University Hypervelocity Impact Laboratory: A..:
Rogers, Jacob A.
;
Bass, Nathaniel
;
Mead, Paul T.
...
Review of Scientific Instruments. 93 (2022) 8 - p. , 2022
Link:
https://doi.org/10.1063/..
1-15